4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001677036-26-000002
Options or other derivatives
- Director acquired 1,370 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lind Kevin Robert Director | 2026-03-31 | Grant or award · Stock Option (Right to Buy) | +1,370 | $12.13 | $16,618 | 1,370 | D |
Loading xslF345X06/form4-04012026_040408.xml…